Policy & Regulation
BioVaxys Technology names new business advisor
19 July 2024 -

Canadian clinical-stage biopharmaceutical company BioVaxys Technology Corp (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) announced on Thursday the appointment of Brittany Davison, CPA, CA as its new business advisor.

Davison, a chartered professional accountant, is the owner of Davison CPA Consulting Inc of Halifax, Nova Scotia. She previously served as chief accounting officer and acting chief financial officer at IMV Inc and as audit senior with Grant Thornton LLP.

Kenneth Kovan, BioVaxys president & chief operating officer, said: "We are delighted to have engaged Brittany who is a significant addition to our team where she will assist with further knowledge transfer associated with the former IMV Inc assets, support investor relations, business development targeting and outreach, and facilitate sources of private funding, government funding and Scientific Research and Experimental Development (SR&ED) tax incentives."

Login
Username:

Password: